[ad_1] Guest Post by Michael A. Caligiuri, MD Last year, the U.S. Food and Drug Administration approved 15 new anticancer therapeutics. More groundbreaking treatments are on the way. Despite this progress, cancer still has a disproportionate impact on disadvantaged and minority groups. In the U.S., black men face more thanRead More →

[ad_1] During the early part of summer 2018, the U.S. Food and Drug Administration (FDA) has approved several new anticancer therapeutics and expanded the use of some previously approved anticancer therapeutics to include new types of cancer. Specifically, the agency approved a new combination of molecularly targeted therapeutics—encorafenib (Braftovi) andRead More →

[ad_1] Biopsies have been an integral part of cancer care for decades. In undiagnosed patients, oncologists can examine suspicious tissues and determine if the cells are benign or malignant. Following diagnosis, biopsies can reveal additional information about a patient’s tumor – What mutations are driving this cancer? Is this patientRead More →

[ad_1] About Childhood Leukemia Cancer Leukemia is the most common form of childhood cancer today, accounting for nearly one-third of all childhood cancer diagnoses in the United States. A blood-based cancer that begins in the soft inner part of the bone called the bone marrow, childhood leukemia is classified intoRead More →

[ad_1] Loriana Hernandez-Aldama is an Emmy Award-winning journalist and former news anchor and medical reporter turned cancer survivor, advocate, and speaker. After being diagnosed with acute myeloid leukemia, she launched ArmorUp for LIFE,  a nonprofit organization that encourages people to change their lives through diet, exercise, and lifestyle before aRead More →